Anavex Life Sciences: D. Boral Capital Raises Buy Rating to $24

martes, 6 de enero de 2026, 9:52 am ET1 min de lectura
AVXL--

Anavex Life Sciences: D. Boral Capital Raises Buy Rating to $24

Anavex Life Sciences: D. Boral Capital Raises Buy Rating to $24

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios